MORGAN STANLEY - AGILE THERAPEUTICS INC ownership

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of AGILE THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$10,000
-74.4%
51,812
-35.4%
0.00%
Q4 2021$39,000
-92.2%
80,244
-84.6%
0.00%
Q3 2021$500,000
-51.1%
520,607
-32.3%
0.00%
Q2 2021$1,023,000
+2076.6%
769,445
+3348.3%
0.00%
Q1 2021$47,000
-77.2%
22,314
-69.0%
0.00%
Q4 2020$206,000
+121.5%
71,943
+135.9%
0.00%
Q3 2020$93,000
-9.7%
30,500
-18.1%
0.00%
Q2 2020$103,000
+1616.7%
37,261
+1142.0%
0.00%
Q1 2020$6,000
-14.3%
3,000
+14.7%
0.00%
Q4 2019$7,0002,615
+1207.5%
0.00%
Q3 2019$02000.0%0.00%
Q2 2019$02000.0%0.00%
Q1 2019$0
-100.0%
200
-98.3%
0.00%
Q4 2018$7,000
-12.5%
11,737
-43.7%
0.00%
Q3 2018$8,000
-52.9%
20,829
-38.4%
0.00%
Q2 2018$17,000
-90.8%
33,829
-53.0%
0.00%
Q1 2018$185,000
-36.0%
71,924
-33.2%
0.00%
Q4 2017$289,000
-25.7%
107,737
+23.7%
0.00%
Q3 2017$389,000
+3436.4%
87,124
+2739.8%
0.00%
Q2 2017$11,000
-91.1%
3,068
-92.0%
0.00%
Q1 2017$124,000
-73.9%
38,382
-54.0%
0.00%
Q4 2016$476,000
+765.5%
83,484
+940.8%
0.00%
Q3 2016$55,000
+129.2%
8,021
+159.4%
0.00%
Q2 2016$24,000
-17.2%
3,092
-32.8%
0.00%
Q1 2016$29,000
-38.3%
4,603
-4.6%
0.00%
Q4 2015$47,000
-11.3%
4,823
-39.6%
0.00%
Q3 2015$53,000
-73.5%
7,979
-65.7%
0.00%
Q2 2015$200,000
-38.5%
23,273
-33.7%
0.00%
Q1 2015$325,000
+8025.0%
35,112
+6922.4%
0.00%
Q3 2014$4,000
-98.5%
500
-98.3%
0.00%
Q2 2014$262,00030,1130.00%
Other shareholders
AGILE THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
CAXTON CORP 2,123,567$12,104,00041.30%
ProQuest Associates IV LLC 5,062,363$28,856,0008.17%
Vivo Capital, LLC 1,513,975$8,630,0002.84%
Aisling Capital LLC 1,804,933$10,288,0002.39%
INVESTOR AB 3,510,189$20,008,0001.46%
AlpInvest Partners B.V. 27,693$158,0000.56%
Cormorant Asset Management, LP 563,880$3,214,0000.43%
PURA VIDA INVESTMENTS, LLC 164,501$938,0000.34%
Perceptive Advisors 661,446$3,770,0000.27%
NEEDHAM INVESTMENT MANAGEMENT LLC 140,000$799,0000.20%
View complete list of AGILE THERAPEUTICS INC shareholders